Press Releases & Awards

September 16, 2021

Dr. J. Curtis Nickel Urinary Microbiome Study Using MicroGenDX NGS Indicates Microbial Diversity Varies by Age and Gender

Dr. J. Curtis Nickel, with the help of MicroGenDX, has completed a study to help understand the implications of Next-Generation DNA Sequencing (NGS) in the diagnosis and treatment of Urinary Tract Infections (UTIs) and other inflammatory urological conditions.…
October 8, 2021

Dr. Karan Goswami Wins EOA Parvizi Musculoskeletal Infection Award

Dr. Karan Goswami of the Rothman Orthopaedic Institute at Thomas Jefferson University has received the prestigious Eastern Orthopaedic Association’s Parvizi Musculoskeletal Infection Award for his paper entitled “Fracture-associated Microbiome and Persistent Nonunion: Next-Generation Sequencing Reveals.” This award is given to a Resident or Fellow with one of the top papers presented at the EOA’s Annual Meeting.…
January 24, 2022

MicroGenDX First Independent Commercial Lab in US Offering NGS for Infections to Appeal Directly to Patients

Using national TV, radio, and web media campaigns, Microgen Diagnostics will be the first independent commercial lab in the U.S. to appeal directly to patients, raising awareness about much more effective DNA analysis alternatives to outdated medical diagnostic technologies like standard culture. The campaign, scheduled for February of 2022, includes testimonials from patients about how MicroGenDX diagnostics helped them – and in some cases saved their lives – when standard cultures failed.…
April 21, 2022

MicroGenDX Acquires Captigen and its Flatswab Inventory

MicroGenDX continues to expand its growth and expertise in molecular diagnostics by acquiring sampling innovator Captigen along with Captigen’s extensive inventory of flatswabs. The Captigen flatswab is a cross-platform precision microbial sampling device designed for optimized culture yield, RT-PCR yield, and next-generation sequencing (NGS).…
June 14, 2022

MicroGenDX Provides Rapid Screening for Candida Auris to Help Avoid Outbreaks in Healthcare Settings

Candida auris causes serious infections, and cases are rising across the U.S…..MicroGenDX testing also facilitates the rapid intervention and precautions needed to prevent outbreaks in healthcare settings by returning results within 24-48 hours.…
February 24, 2023

MicroGenDX Next-Generation Sequencing PJI Study Named as JBJS Notable Article of 2022

The landmark 14-Site study on the role of Next-Generation Sequencing in Periprosthetic Joint Infections has been acknowledged by the journal as being one of the ten that “will have the greatest impact on patient care.”…
Translate »
Shopping cart0
There are no products in the cart!
Continue shopping
0